VACCINEX, INC. - FORM S-1 - EX-23.1 - July 9, 2018

Attached files

file filename
EX-10.13 - EX-10.13 - VACCINEX, INC.d515130dex1013.htm
EX-10.15 - EX-10.15 - VACCINEX, INC.d515130dex1015.htm
EX-21.1 - EX-21.1 - VACCINEX, INC.d515130dex211.htm
EX-10.22 - EX-10.22 - VACCINEX, INC.d515130dex1022.htm
EX-10.21 - EX-10.21 - VACCINEX, INC.d515130dex1021.htm
EX-10.20 - EX-10.20 - VACCINEX, INC.d515130dex1020.htm
EX-10.19 - EX-10.19 - VACCINEX, INC.d515130dex1019.htm
EX-10.18 - EX-10.18 - VACCINEX, INC.d515130dex1018.htm
EX-10.17 - EX-10.17 - VACCINEX, INC.d515130dex1017.htm
EX-10.16 - EX-10.16 - VACCINEX, INC.d515130dex1016.htm
EX-10.14 - EX-10.14 - VACCINEX, INC.d515130dex1014.htm
EX-10.12 - EX-10.12 - VACCINEX, INC.d515130dex1012.htm
EX-10.11 - EX-10.11 - VACCINEX, INC.d515130dex1011.htm
EX-10.9 - EX-10.9 - VACCINEX, INC.d515130dex109.htm
EX-10.5 - EX-10.5 - VACCINEX, INC.d515130dex105.htm
EX-10.4 - EX-10.4 - VACCINEX, INC.d515130dex104.htm
EX-10.3 - EX-10.3 - VACCINEX, INC.d515130dex103.htm
EX-10.2 - EX-10.2 - VACCINEX, INC.d515130dex102.htm
EX-10.1 - EX-10.1 - VACCINEX, INC.d515130dex101.htm
EX-4.1 - EX-4.1 - VACCINEX, INC.d515130dex41.htm
EX-3.17 - EX-3.17 - VACCINEX, INC.d515130dex317.htm
EX-3.16 - EX-3.16 - VACCINEX, INC.d515130dex316.htm
EX-3.15 - EX-3.15 - VACCINEX, INC.d515130dex315.htm
EX-3.14 - EX-3.14 - VACCINEX, INC.d515130dex314.htm
EX-3.13 - EX-3.13 - VACCINEX, INC.d515130dex313.htm
EX-3.12 - EX-3.12 - VACCINEX, INC.d515130dex312.htm
EX-3.11 - EX-3.11 - VACCINEX, INC.d515130dex311.htm
EX-3.10 - EX-3.10 - VACCINEX, INC.d515130dex310.htm
EX-3.9 - EX-3.9 - VACCINEX, INC.d515130dex39.htm
EX-3.8 - EX-3.8 - VACCINEX, INC.d515130dex38.htm
EX-3.7 - EX-3.7 - VACCINEX, INC.d515130dex37.htm
EX-3.6 - EX-3.6 - VACCINEX, INC.d515130dex36.htm
EX-3.5 - EX-3.5 - VACCINEX, INC.d515130dex35.htm
EX-3.4 - EX-3.4 - VACCINEX, INC.d515130dex34.htm
EX-3.3 - EX-3.3 - VACCINEX, INC.d515130dex33.htm
EX-3.2 - EX-3.2 - VACCINEX, INC.d515130dex32.htm
EX-3.1 - EX-3.1 - VACCINEX, INC.d515130dex31.htm
S-1 - S-1 - VACCINEX, INC.d515130ds1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated April 13, 2018 relating to the consolidated financial statements of Vaccinex, Inc. and subsidiaries (which report expresses an unqualified opinion and includes an explanatory paragraph regarding a going concern uncertainty) appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to us under the heading “Experts” in such Prospectus.

/s/ Deloitte & Touche LLP

Rochester, New York

July 9, 2018

VACCINEX, INC. Reports